Perbedaan Pelayaran Jaya Hidup Baru Tbk. dan Organon Pharma Indonesia Tbk.: Pelayaran Jaya Hidup Baru Tbk. diperdagangkan di Rp181 (kapitalisasi pasar 351,55 M, volume 24 jam 1,7 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Pelayaran Jaya Hidup Baru Tbk. jauh lebih besar — sekitar 3,4× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| PJHB | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 351,55 M | 104,4 M |
Volume | 1,7 jt | — |
Lot | 17,03 rb | — |
Perputaran | 306,54 jt | — |
Harga Rata-rata | 179,99 | — |
Nilai Transaksi | 306,54 jt | — |
Harga Ekuilibrium Indikatif | 181 | — |
Volume Ekuilibrium Indikatif | 517 | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Pelayaran Jaya Hidup Baru Tbk. hereinafter referred to as the Company, was established under the name PT. Pelayaran Dalam Negeri Jaya Hidup Baru in Surabaya based on the Deed of Notary Susanto Tjiptowidjojo, S.H., Number 3 dated October 9, 2008. The Company controlling shareholder is Hero Gozali.
Selengkapnya di halaman PJHB →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →